NCT05218265View on ClinicalTrials.gov

Criteria and Potential Predictors of Severity in Patients With COVID-19

CompletedOBSERVATIONAL

Enrollment

202

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

July 30, 2021

Conditions

COVID-19

Interventions

DIAGNOSTIC_TEST

routine laboratory tests

Complete blood count (CBC), coagulation profile, serum biochemical tests (including renal and liver function, and electrolytes), laboratory investigation to assess severity of COVID-19: lactate dehydrogenase (LDH), myocardial enzymes (CPK-MB), serum ferritin, D dimer and arterial blood gases analysis

Trial Locations (1)

44519

Zagazig University Faculty of medicine Chest Department, Zagazig

All Listed Sponsors

lead

Zagazig University

OTHER_GOV

NCT05218265 - Criteria and Potential Predictors of Severity in Patients With COVID-19 | Biotech Hunter | Biotech Hunter